| Date Filed | Type | Description |
| 05/16/2023 |
4
| HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 152 options to buy
@ $0 |
|
| 05/16/2023 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 485 options to buy
@ $0 |
|
| 05/16/2023 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 1,818 options to buy
@ $0 |
|
| 03/09/2023 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 61 options to buy
@ $0 |
|
| 03/09/2023 |
4
| HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 545 options to buy
@ $0 |
|
| 03/09/2023 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 545 options to buy
@ $0 |
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Grove Janet P (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Granted 840 options to buy
@ $1.78, valued at
$1.5k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 1,515 options to buy
@ $0 |
|
| 06/02/2022 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 13,636 options to buy
@ $0 |
|
| 05/19/2022 |
4
| Baldasare Bryan T (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Granted 14,000 options to buy
@ $0.8, valued at
$11.2k
|
|
| 04/18/2022 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Bought 14,160 shares
@ $0.894, valued at
$12.7k
|
|
| 04/13/2022 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Bought 8,560 shares
@ $0.85, valued at
$7.3k
|
|
| 02/28/2022 |
4
| WOUDENBERG MICHAEL (See Remarks) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.01, valued at
$5.1k
|
|
| 02/23/2022 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 3,030 options to buy
@ $0 |
|
| 02/22/2022 |
4
| Grove Janet P (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Granted 14,000 options to buy
@ $1.12, valued at
$15.7k
|
|
| 01/24/2022 |
4
| Garner William J (Director) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 24,242 options to buy
@ $0 |
|
| 01/24/2022 |
4
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 60,606 options to buy
@ $0 |
|
| 01/24/2022 |
4
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 12,121 options to buy
@ $0 |
|
|